A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases

Simone Cesaro, Roberta Corrò, Anna Pelosin, Piergiorgio Gamba, Nicola Zadra, Fabio Fusaro, Marta Pillon, Riccardo Cusinato, Chiara Zampieri, Laura Magagna, Mara Cavaliere, Gloria Tridello, Gianfranco Zanon, Luigi Zanesco

Research output: Contribution to journalArticle

Abstract

A prospective pediatric survey on the incidence of central venous catheter (CVC) complications was performed aimed at identifying risk factors of premature CVC removal. The study comprised 129 Broviac-Hickman CVCs inserted during a 13-month period in 112 children. The total number of CVC days was 19,328 (median: 122 days, range: 1-385). The overall rate of complications was 6.2/1000 CVC days, i.e., 4.5/1000 and 1.7/1000 CVC days for mechanical and infectious complications, respectively. Interestingly, only two CVC-related cases of septicemia and no thrombotic events were documented. At the end of the study period, 38 of 129 CVC (29.5%) had been removed: 20 due to CVC-related complications (dislocation18, rupture 2), 10 due to the patient's death, and 8 due to completion of therapy. Age at CVC insertion

Original languageEnglish
Pages (from-to)183-188
Number of pages6
JournalAnnals of Hematology
Volume83
Issue number3
DOIs
Publication statusPublished - Mar 2004

Fingerprint

Central Venous Catheters
Hematologic Diseases
Catheters
Pediatrics
Incidence
Surveys and Questionnaires
Rupture
Sepsis

Keywords

  • Broviac/Hickman central venous catheter
  • Complications
  • Infections
  • Pediatric malignancy

ASJC Scopus subject areas

  • Hematology

Cite this

A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. / Cesaro, Simone; Corrò, Roberta; Pelosin, Anna; Gamba, Piergiorgio; Zadra, Nicola; Fusaro, Fabio; Pillon, Marta; Cusinato, Riccardo; Zampieri, Chiara; Magagna, Laura; Cavaliere, Mara; Tridello, Gloria; Zanon, Gianfranco; Zanesco, Luigi.

In: Annals of Hematology, Vol. 83, No. 3, 03.2004, p. 183-188.

Research output: Contribution to journalArticle

Cesaro, S, Corrò, R, Pelosin, A, Gamba, P, Zadra, N, Fusaro, F, Pillon, M, Cusinato, R, Zampieri, C, Magagna, L, Cavaliere, M, Tridello, G, Zanon, G & Zanesco, L 2004, 'A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases', Annals of Hematology, vol. 83, no. 3, pp. 183-188. https://doi.org/10.1007/s00277-003-0796-9
Cesaro, Simone ; Corrò, Roberta ; Pelosin, Anna ; Gamba, Piergiorgio ; Zadra, Nicola ; Fusaro, Fabio ; Pillon, Marta ; Cusinato, Riccardo ; Zampieri, Chiara ; Magagna, Laura ; Cavaliere, Mara ; Tridello, Gloria ; Zanon, Gianfranco ; Zanesco, Luigi. / A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. In: Annals of Hematology. 2004 ; Vol. 83, No. 3. pp. 183-188.
@article{93bedd96db0c438eb287895fc19f4f5a,
title = "A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases",
abstract = "A prospective pediatric survey on the incidence of central venous catheter (CVC) complications was performed aimed at identifying risk factors of premature CVC removal. The study comprised 129 Broviac-Hickman CVCs inserted during a 13-month period in 112 children. The total number of CVC days was 19,328 (median: 122 days, range: 1-385). The overall rate of complications was 6.2/1000 CVC days, i.e., 4.5/1000 and 1.7/1000 CVC days for mechanical and infectious complications, respectively. Interestingly, only two CVC-related cases of septicemia and no thrombotic events were documented. At the end of the study period, 38 of 129 CVC (29.5{\%}) had been removed: 20 due to CVC-related complications (dislocation18, rupture 2), 10 due to the patient's death, and 8 due to completion of therapy. Age at CVC insertion",
keywords = "Broviac/Hickman central venous catheter, Complications, Infections, Pediatric malignancy",
author = "Simone Cesaro and Roberta Corr{\`o} and Anna Pelosin and Piergiorgio Gamba and Nicola Zadra and Fabio Fusaro and Marta Pillon and Riccardo Cusinato and Chiara Zampieri and Laura Magagna and Mara Cavaliere and Gloria Tridello and Gianfranco Zanon and Luigi Zanesco",
year = "2004",
month = "3",
doi = "10.1007/s00277-003-0796-9",
language = "English",
volume = "83",
pages = "183--188",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases

AU - Cesaro, Simone

AU - Corrò, Roberta

AU - Pelosin, Anna

AU - Gamba, Piergiorgio

AU - Zadra, Nicola

AU - Fusaro, Fabio

AU - Pillon, Marta

AU - Cusinato, Riccardo

AU - Zampieri, Chiara

AU - Magagna, Laura

AU - Cavaliere, Mara

AU - Tridello, Gloria

AU - Zanon, Gianfranco

AU - Zanesco, Luigi

PY - 2004/3

Y1 - 2004/3

N2 - A prospective pediatric survey on the incidence of central venous catheter (CVC) complications was performed aimed at identifying risk factors of premature CVC removal. The study comprised 129 Broviac-Hickman CVCs inserted during a 13-month period in 112 children. The total number of CVC days was 19,328 (median: 122 days, range: 1-385). The overall rate of complications was 6.2/1000 CVC days, i.e., 4.5/1000 and 1.7/1000 CVC days for mechanical and infectious complications, respectively. Interestingly, only two CVC-related cases of septicemia and no thrombotic events were documented. At the end of the study period, 38 of 129 CVC (29.5%) had been removed: 20 due to CVC-related complications (dislocation18, rupture 2), 10 due to the patient's death, and 8 due to completion of therapy. Age at CVC insertion

AB - A prospective pediatric survey on the incidence of central venous catheter (CVC) complications was performed aimed at identifying risk factors of premature CVC removal. The study comprised 129 Broviac-Hickman CVCs inserted during a 13-month period in 112 children. The total number of CVC days was 19,328 (median: 122 days, range: 1-385). The overall rate of complications was 6.2/1000 CVC days, i.e., 4.5/1000 and 1.7/1000 CVC days for mechanical and infectious complications, respectively. Interestingly, only two CVC-related cases of septicemia and no thrombotic events were documented. At the end of the study period, 38 of 129 CVC (29.5%) had been removed: 20 due to CVC-related complications (dislocation18, rupture 2), 10 due to the patient's death, and 8 due to completion of therapy. Age at CVC insertion

KW - Broviac/Hickman central venous catheter

KW - Complications

KW - Infections

KW - Pediatric malignancy

UR - http://www.scopus.com/inward/record.url?scp=10744225167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744225167&partnerID=8YFLogxK

U2 - 10.1007/s00277-003-0796-9

DO - 10.1007/s00277-003-0796-9

M3 - Article

C2 - 15064868

AN - SCOPUS:10744225167

VL - 83

SP - 183

EP - 188

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 3

ER -